LabGenomics Balance Sheet Health
Financial Health criteria checks 3/6
LabGenomics has a total shareholder equity of ₩225.7B and total debt of ₩42.9B, which brings its debt-to-equity ratio to 19%. Its total assets and total liabilities are ₩304.4B and ₩78.7B respectively.
Key information
19.0%
Debt to equity ratio
₩42.92b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩105.95b |
| Equity | ₩225.71b |
| Total liabilities | ₩78.74b |
| Total assets | ₩304.45b |
Recent financial health updates
Is LabGenomics (KOSDAQ:084650) Weighed On By Its Debt Load?
Nov 08
Is LabGenomics (KOSDAQ:084650) Using Too Much Debt?
Jul 27Recent updates
Not Many Are Piling Into LabGenomics Co., Ltd. (KOSDAQ:084650) Stock Yet As It Plummets 26%
Nov 17Is LabGenomics (KOSDAQ:084650) Weighed On By Its Debt Load?
Nov 08Slammed 29% LabGenomics Co., Ltd. (KOSDAQ:084650) Screens Well Here But There Might Be A Catch
Sep 21Market Might Still Lack Some Conviction On LabGenomics Co., Ltd. (KOSDAQ:084650) Even After 35% Share Price Boost
Aug 06Is LabGenomics (KOSDAQ:084650) Using Too Much Debt?
Jul 27Market Still Lacking Some Conviction On LabGenomics Co., Ltd. (KOSDAQ:084650)
Apr 09If You Like EPS Growth Then Check Out LabGenomics (KOSDAQ:084650) Before It's Too Late
Mar 31Financial Position Analysis
Short Term Liabilities: A084650's short term assets (₩149.7B) exceed its short term liabilities (₩76.1B).
Long Term Liabilities: A084650's short term assets (₩149.7B) exceed its long term liabilities (₩2.6B).
Debt to Equity History and Analysis
Debt Level: A084650 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A084650's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A084650's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A084650's interest payments on its debt are well covered by EBIT.